Peter G. Abram

Director of Finance/CFO at MDS Pharma Services (Canada)

Commercial Services

Consumer Services

Producer Manufacturing

Profile

Peter G.
Abram is currently the Chief Financial Officer & Senior Vice President at MDS Pharma Services (Canada) since 2005.
Prior to this, he worked as a Manager-Financial Planning & Reporting at General Electric Co. He also served as the Chief Financial Officer & Senior Vice President at FARO Technologies, Inc. from 2014 to 2015.
Mr. Abram completed his undergraduate degree from Miami University.

Peter G. Abram active positions

Companies	Position	Start
MDS Pharma Services (Canada) MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada.	Director of Finance/CFO	06/09/2005

All active positions of Peter G. Abram

Former positions of Peter G. Abram

Companies	Position	End
FARO TECHNOLOGIES, INC.	Director of Finance/CFO	20/03/2015
GE AEROSPACE	Corporate Officer/Principal	-

See the detail of Peter G. Abram's experience

Training of Peter G. Abram

Miami University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter G. Abram's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GE AEROSPACE	Producer Manufacturing
FARO TECHNOLOGIES, INC.	Electronic Technology

Private companies	1
MDS Pharma Services (Canada) MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada.	Commercial Services